The study demonstrated that high pretreatment plasma levels of OPN, CA IX and VEGF were correlated with impaired prognosis in M0-stage NSCLC patients receiving radical radiotherapy, which is in a good concordance with the present results. This evidence concerns the gene VEGFA and non-small cell lung carcinoma.